Metallothioneins are neuroprotective agents in lysosomal storage disorders

E-ISSN： 1531-8249|83|2|418-432

ISSN： 0364-5134

Source： ANNALS OF NEUROLOGY, Vol.83, Iss.2, 2018-02, pp. : 418-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Transfer Strategies for Correction of Lysosomal Storage Disorders

Acta Haematologica, Vol. 110, Iss. 2-3, 2003-10 ,pp. : 71-85

Karger

Access to resources Recommend Favorite

Inherited metabolic disorders: prenatal diagnosis of lysosomal storage disorders

PRENATAL DIAGNOSIS, Vol. 35, Iss. 11, 2015-11 ,pp. : 1137-1147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Villa Metabolica – a center of excellence for the diagnosis and treatment of lysosomal storage disorders

By Beck Michael

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 23-24, 2010-12 ,pp. : 625-626

Springer Publishing Company

Access to resources Recommend Favorite

A Review of Agents Patented for their Neuroprotective Properties

Recent Patents on CNS Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 139-146

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 1-19

Bentham Science Publishers

Access to resources Recommend Favorite